Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Uremia, a condition also known as uremic syndrome or azotemia, is caused by the build-up of waste products in the bloodstream due to kidney failure. The kidneys are responsible for removing toxins and excess fluids from the body, but when they stop functioning properly, these waste products accumulate and can cause a range of symptoms. These might include fatigue, loss of appetite, nausea and vomiting, confusion, seizures and even coma in severe cases. Uremia can affect people at any age but is more commonly observed in older individuals with pre-existing conditions such as diabetes or high blood pressure. If left untreated or unmanaged over time, it can lead to permanent damage to multiple organs throughout the body including the heart and brain.
1.
Waiting for a Sharp Increase in Prostate Cancer Cases.
2.
The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.
3.
Journal Club: A well-accepted and safe method for soft tissue sarcoma biopsy.
4.
Which Risk Model Better Identifies High-Risk Smoldering MM?
5.
Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.
1.
The Danger of Methemoglobinemia and How to Prevent It
2.
Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment
3.
Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment
4.
Everything You Need to Know About Normal Potassium Levels
5.
The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
4.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge